Advanced Biomed (ADVB) Cash & Current Investments (2023 - 2026)

Advanced Biomed has disclosed Cash & Current Investments across 4 years of filings, most recently posting $2.6 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $2.6 million, down 17.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 17.75% YoY), and the FY2025 annual result was $2.9 million, up 11.42% from the prior year.
• Cash & Current Investments came in at $2.6 million for Q1 2026 at Advanced Biomed, roughly flat from $2.6 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $3.2 million in Q1 2025 to a low of $2.6 million in Q2 2024.
• The 4-year median for Cash & Current Investments is $2.7 million (2024), against an average of $2.7 million.
• Across the five-year window, Cash & Current Investments grew 19.25% in 2025 and dropped 17.75% in 2026, its largest moves.
• Advanced Biomed's Cash & Current Investments stood at $2.8 million in 2023, then slipped by 4.64% to $2.6 million in 2024, then slipped by 1.13% to $2.6 million in 2025, then slipped by 0.19% to $2.6 million in 2026.
• The last three Cash & Current Investments figures came in at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.